Received Aug 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID after Pfizer COVID shots; COVID after Pfizer COVID shots; Asthma; COPD; This is a spontaneous report received from a Consumer or other non HCP. A 70-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Primary immunization series completed), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID after Pfizer COVID shots"; ASTHMA (non-serious), outcome "unknown"; CHRONIC OBSTRUCTIVE PULMONARY DISEASE (non-serious), outcome "unknown", described as "COPD". The events "covid after pfizer covid shots", "asthma" and "copd" required physician office visit. Additional information: patient went to the pharmacy, diagnosed with COVID, for Paxlovid. The doctors prescribed this medication from Urgent Care. Patient had asthma with COPD. All his shots were with Pfizer and added he "got all of them except the last one" and his primary doctor told him to wait a while to get it cause he had done all the rest of them. Patient added "the last one got bout the same thing that the one before that had in it". Primary doctor will let him know when to come get it (COVID shot). The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.